Risk Factors for COVID-19 Mortality

  • End date
    Dec 31, 2021
  • participants needed
  • sponsor
    Teodoro Marcianò
Updated on 17 March 2021


COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symptoms, generally flu-like symptoms. Predicting clinical worsening could help to address major efforts towards higher risk patients.

During the last year most observational studies, generally retrospective, has been conducted, identifying some risk factors such as age, obesity, male gender, cardiovascular disease, COPD, diabetes etc.

The study goal is to collect systematically a variegate amount of clinical, biometric, laboratory and radiological data from patients admitted to the Emergency Medicine Ward of Piacenza Hospital (Italy), in order to prospectively analyze what characteristics are associated to higher risk of mortality.

Condition Pulmonary Disease, Population at Risk, ADULT RESPIRATORY DISTRESS SYNDROME, Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress, Lung Disease, acute respiratory distress syndrome, ards, COVID-19 Virus Infection, COVID-19 Virus Infection
Clinical Study IdentifierNCT04786808
SponsorTeodoro Marcianò
Last Modified on17 March 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Lung Disease or ADULT RESPIRATORY DISTRESS SYNDROME or Pulmonary Disease or ards or Population at Risk or Acute Respiratory Distress or Acute Respirat...?
Do you have any of these conditions: Population at Risk or acute respiratory distress syndrome or ards or Acute Respiratory Distress or COVID-19 Virus Infection or ADULT RESPIRATORY DISTR...?
Admission to the Emergency Medicine Ward from the Emergency Department of Piacenza Hospital (Italy)
Confirmed COVID-19 diagnosis through molecular test obtained from nasal-pharyngeal swabs in the Emergency Department
Age above 18

Exclusion Criteria

inability to obtain an informed consent due to neurological conditions
patient's refusal to sign the informed consent
inability of researchers to recruit the patient in the first 24 hours from the admission
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note